An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment

Author： Caffo Orazio Dipasquale Mariachiara Murgia Viviana Veccia Antonello Galligioni Enzo

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.8, 2013-08, pp. : 1037-1051

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma

By Foss Francine M

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1141-1152

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Use of Infliximab

By Klotz Ulrich Teml Alexander Schwab Matthias

Clinical Pharmacokinetics, Vol. 46, Iss. 8, 2007-01 ,pp. : 645-660

Adis International

Access to resources Recommend Favorite

Gemcitabine plus vinorelbine superior in NSCLC

Inpharma, Vol. 1, Iss. 1251, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

ICER favours vinorelbine + cisplatin for NSCLC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 534, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Docetaxel: clinical benefit in first-line treatment for NSCLC

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite